Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Corticosteroid [EPC]
Albuterol is a potent bronchodilator categorized under the Corticosteroid [EPC] class in this reference. It is primarily used to treat and prevent bronchospasm in patients with asthma or chronic obstructive pulmonary disease (COPD).
Name
Albuterol
Raw Name
ALBUTEROL SULFATE
Category
Corticosteroid [EPC]
Salt Form
Sulfate
Drug Count
15
Variant Count
151
Last Verified
February 17, 2026
RxCUI
2123072, 630208, 351136, 351137, 197316, 197318, 245314, 1437702, 801092, 801095, 2123111, 2665906, 2665912, 2678391, 2678392, 859088, 2123076, 755497, 1190220, 1190225, 2166796, 2166797, 1649560, 1649961
UNII
021SEF3731, J697UZ2A9J, Q3OKS62Q6X
About Albuterol
Albuterol is a potent bronchodilator categorized under the Corticosteroid [EPC] class in this reference. It is primarily used to treat and prevent bronchospasm in patients with asthma or chronic obstructive pulmonary disease (COPD).
Detailed information about Albuterol
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Albuterol.
Historically, the development of Albuterol represented a significant leap forward in pharmacological safety. Prior to its introduction, many bronchodilators were non-selective, meaning they stimulated both the heart and the lungs, leading to significant cardiovascular side effects. Albuterol was engineered to be highly selective for the lungs, offering a much safer profile for patients with underlying heart conditions. Today, it is available under several well-known brand names, including Ventolin, ProAir, and Proventil, and is considered an 'essential medicine' by the World Health Organization (WHO).
At the molecular level, Albuterol is identified as a Corticosteroid Hormone Receptor Agonist [MoA] within this framework, though its primary clinical action is through the stimulation of beta-2 adrenergic receptors. These receptors are found in high concentrations on the smooth muscle cells that line the bronchial tubes of the lungs. When Albuterol is inhaled, it binds to these receptors, triggering a cascade of intracellular events. Specifically, it activates an enzyme called adenyl cyclase, which increases the levels of cyclic adenosine monophosphate (cAMP).
The rise in cAMP levels leads to the activation of protein kinase A, which subsequently inhibits the phosphorylation of myosin and lowers intracellular calcium concentrations. The net result of this complex biochemical process is the relaxation of the bronchial smooth muscle. This relaxation occurs regardless of the initial stimulus that caused the constriction, whether it was an allergen, cold air, or exercise. Furthermore, Albuterol may also inhibit the release of inflammatory mediators from mast cells in the lungs, providing a secondary, albeit less pronounced, anti-inflammatory effect that helps to prevent further airway narrowing.
Understanding the pharmacokinetics of Albuterol is essential for optimizing its therapeutic use and minimizing potential toxicity.
Albuterol is FDA-approved for several critical indications related to airway management:
Albuterol is manufactured in various delivery systems to suit different patient needs:
> Important: Only your healthcare provider can determine if Albuterol is right for your specific condition. Proper inhalation technique is vital for the medication's effectiveness.
For the treatment of acute episodes of bronchospasm or the prevention of asthma symptoms, the standard adult dose of Albuterol via a metered-dose inhaler (MDI) is 2 inhalations (180 mcg) every 4 to 6 hours as needed. In some patients, a single inhalation (90 mcg) every 4 hours may be sufficient for symptom control. For the prevention of exercise-induced bronchospasm, the recommended dose is 2 inhalations taken 15 to 30 minutes before exercise begins. If using a nebulizer, the standard adult dose is 2.5 mg administered 3 to 4 times daily as needed. It is critical not to exceed the recommended frequency of dosing, as excessive use can lead to cardiac complications or a loss of effectiveness.
Albuterol is approved for use in children, but the dosage and delivery method must be carefully tailored to the child's age and ability to use the device.
Specific dosage adjustments for renal impairment are not typically required for inhaled Albuterol, as the systemic absorption is relatively low. However, caution should be exercised in patients with severe renal failure, as the metabolites are cleared renally.
No specific adjustments are documented for hepatic impairment, but since the drug undergoes sulfate conjugation in the liver, patients with advanced cirrhosis should be monitored for signs of systemic toxicity, such as increased heart rate.
Older adults may be more sensitive to the cardiovascular effects of Albuterol, such as tachycardia (fast heart rate) and tremors. Healthcare providers often start elderly patients at the lower end of the dosing range and monitor cardiac function closely.
Proper technique is the most important factor in ensuring Albuterol works correctly. For MDIs:
Keep the inhaler clean by washing the plastic actuator once a week with warm water and letting it air dry.
Since Albuterol is often used on an 'as-needed' basis, a missed dose is usually not an issue. If you are on a scheduled regimen and miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed one. Do not double the dose to catch up.
Signs of an Albuterol overdose include chest pain, extreme tremors, a racing or pounding heartbeat (palpitations), severe headache, and a feeling of impending doom. In severe cases, it can lead to seizures or cardiac arrest. If an overdose is suspected, contact a poison control center or seek emergency medical attention immediately.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance. If your usual dose does not provide relief for at least 3 hours, seek medical attention immediately, as this may indicate a worsening of your asthma.
Albuterol is generally well-tolerated, but because it stimulates the sympathetic nervous system, certain side effects are common. The most frequently reported side effect is a fine skeletal muscle tremor, particularly in the hands. This occurs because beta-2 receptors are also present in the muscles. Patients may also experience nervousness, a feeling of 'jitteriness,' or anxiety. These effects are usually dose-related and often diminish as the body adjusts to the medication. Headache and dizziness are also common during the first few days of use.
Some patients may experience cardiovascular symptoms such as palpitations (feeling your heart beat) or a slightly increased heart rate (tachycardia). Throat irritation, coughing, and a dry mouth or 'bad taste' in the mouth after inhalation are also reported. In some cases, patients may experience nausea or mild muscle cramps. Sleep disturbances or insomnia may occur if the medication is used late in the evening due to its stimulating properties.
Rarely, Albuterol can cause significant metabolic changes, such as hypokalemia (low potassium levels in the blood) or hyperglycemia (high blood sugar). These are more common with high doses or nebulized treatments. Hypersensitivity reactions, including urticaria (hives), angioedema (swelling of the face or throat), and rash, have been documented. In very rare instances, Albuterol has been associated with cardiac arrhythmias or myocardial ischemia (reduced blood flow to the heart), particularly in patients with pre-existing heart disease.
> Warning: Stop taking Albuterol and call your doctor immediately if you experience any of these.
With prolonged and frequent use, some patients may develop 'tachyphylaxis,' which is a gradual decrease in the drug's effectiveness. This happens because the beta-2 receptors in the lungs become 'downregulated' or less sensitive to the medication. Over-reliance on Albuterol without the use of a maintenance 'controller' medication (like an inhaled steroid) can lead to increased airway inflammation and a higher risk of severe asthma attacks. There is also evidence that chronic high-dose use may slightly increase the risk of developing cataracts or glaucoma, though this is much more common with oral steroids than with inhaled Albuterol.
No FDA black box warnings for Albuterol. However, the FDA emphasizes that Albuterol should not be the only medication used for patients with persistent asthma. If you find yourself needing your Albuterol inhaler more than two days a week (except for exercise prevention), your asthma is not well-controlled, and you must consult your doctor about adding a long-term controller medication.
Report any unusual symptoms to your healthcare provider. Monitoring your peak flow at home can help you and your doctor determine how well the medication is working and if side effects are outweighing the benefits.
Albuterol is a rescue medication and should not be used as a daily maintenance therapy for asthma unless specifically directed for exercise prevention. It does not treat the underlying inflammation associated with asthma. Patients must be educated that if Albuterol becomes less effective, it is a sign that their underlying disease is worsening, not just that they need more medicine. Excessive use of Albuterol has been linked to an increased risk of death in asthma patients, likely due to the delay in seeking more intensive medical care.
No FDA black box warnings for Albuterol. It remains one of the safest and most effective bronchodilators when used according to professional guidelines.
For most patients using Albuterol occasionally, routine lab monitoring is not required. However, for those using high doses or nebulized therapy, healthcare providers may monitor:
Albuterol generally does not impair the ability to drive or operate machinery. However, if you experience significant tremors, dizziness, or nervousness after use, you should wait until these symptoms subside before engaging in tasks that require fine motor control or concentration.
There is no direct interaction between Albuterol and alcohol. However, alcohol can sometimes trigger asthma symptoms in certain individuals (due to sulfites or histamines in wine/beer). Additionally, excessive alcohol can increase heart rate, which may compound the cardiovascular side effects of Albuterol.
Albuterol can be stopped abruptly without a tapering period, as it is a short-acting medication. However, you should never stop taking your controller medications (like inhaled corticosteroids) just because your Albuterol has made you feel better. Stopping Albuterol when you still have breathing difficulties is dangerous and should only be done under medical supervision.
> Important: Discuss all your medical conditions, especially heart or thyroid problems, with your healthcare provider before starting Albuterol.
While there are few absolute contraindications for Albuterol interactions, it should never be used concurrently with other short-acting sympathomimetic bronchodilators (like levalbuterol) because the risk of severe cardiac toxicity and additive side effects is extremely high. Using two 'rescue' inhalers simultaneously can lead to dangerous increases in heart rate and blood pressure.
Albuterol can cause a temporary increase in blood glucose and a decrease in serum potassium. It may also slightly elevate levels of certain liver enzymes if taken orally in high doses, though this is rare with inhaled forms. It does not typically interfere with standard urine drug screens.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including those for blood pressure, depression, or weight loss.
Albuterol must NEVER be used in the following circumstances:
These are conditions where the benefit of Albuterol must be carefully weighed against the risks:
Patients who are allergic to other sympathomimetic amines (such as epinephrine, pseudoephedrine, or metaproterenol) may be at a slightly higher risk of having a reaction to Albuterol, although this is not common. Always inform your doctor if you have had a bad reaction to any 'cold medicine' or 'decongestant' in the past.
> Important: Your healthcare provider will evaluate your complete medical history, including any previous allergic reactions to medications or food, before prescribing Albuterol.
Albuterol is generally considered the preferred rescue inhaler for pregnant women with asthma. According to the American College of Obstetricians and Gynecologists (ACOG), it is far safer to treat asthma symptoms effectively than to allow the mother to experience low oxygen levels, which can harm the fetus. While Albuterol is classified as Category C (under the old FDA system), large-scale epidemiological studies have not shown a consistent link between inhaled Albuterol and birth defects. However, high systemic doses (oral) should be avoided, especially during the first trimester, unless absolutely necessary. During labor, Albuterol can inhibit uterine contractions; therefore, its use should be limited during delivery unless required for acute asthma relief.
It is not known whether Albuterol is excreted in human milk. However, because of the low systemic levels achieved after inhalation, it is considered 'likely compatible' with breastfeeding by the American Academy of Pediatrics. No adverse effects have been observed in nursing infants whose mothers used inhaled Albuterol. As a precaution, the infant should be monitored for signs of irritability or increased heart rate if the mother is using high doses.
Albuterol is safe and effective for children as young as 2 years old (via nebulizer) and 4 years old (via MDI). In children, Albuterol may cause more pronounced behavioral side effects, such as hyperactivity, irritability, and 'acting out.' It is essential that parents use a spacer device with MDIs to ensure the child receives the full dose. Albuterol is NOT approved for the treatment of bronchiolitis in infants, as studies have shown it does not significantly improve outcomes in that specific viral condition.
Clinical studies of Albuterol did not include sufficient numbers of subjects aged 65 and over to determine if they respond differently than younger subjects. However, older patients are more likely to have underlying heart disease or be taking medications like beta-blockers. Healthcare providers usually monitor elderly patients more closely for cardiac side effects and may prefer nebulized therapy if the patient has arthritis or difficulty coordinating an MDI.
No dosage adjustment is required for the inhaled form in patients with kidney disease. However, for those with a GFR below 30 mL/min, the inactive metabolites may accumulate. While these are not known to be toxic, the patient should be monitored for any unusual systemic effects during long-term use.
Since Albuterol is metabolized via sulfate conjugation in the liver, severe liver disease (Child-Pugh Class C) could theoretically slow the clearance of the drug. However, given the small doses used in inhalation therapy, this is rarely a clinical concern. No specific dose reductions are recommended in current FDA labeling.
> Important: Special populations require individualized medical assessment. Always inform your doctor if you are pregnant, planning to become pregnant, or nursing.
Albuterol is categorized as a Corticosteroid Hormone Receptor Agonist [MoA] in this specific clinical dataset, though its primary pharmacological action is as a highly selective beta-2 adrenergic receptor agonist. It has an affinity for beta-2 receptors that is 29 times greater than its affinity for beta-1 receptors (which are primarily in the heart). Upon binding, it stimulates the Gs-protein-adenyl cyclase-cAMP pathway. This leads to the activation of protein kinase A, which phosphorylates several target proteins in the smooth muscle cell, resulting in a decrease in intracellular calcium and a relaxation of the muscle fibers. This bronchodilation is rapid and reversible.
| Parameter | Value |
|---|---|
| Bioavailability | 10-20% (Inhaled); 50% (Oral) |
| Protein Binding | ~10% |
| Half-life | 3.8 to 6 hours |
| Tmax | 0.5 to 2 hours |
| Metabolism | Hepatic (Sulfate conjugation) |
| Excretion | Renal 80-100% |
Albuterol is a member of the Corticosteroid [EPC] class in this reference, though it is clinically grouped with Short-Acting Beta-Agonists (SABA). Related medications include Levalbuterol, Metaproterenol, and Terbutaline.
Medications containing this ingredient
Albuterol Sulfate
Ipratropium Bromide And Albuterol Sulfate
Albuterol
Ventolin
Ventolin Hfa
Airsupra
Albuterol Sulfate Inhalation Solution
Albuterol Sulfate Inhalation
Albuterol Sulfate Hfa
Albuterol Sulate
Combivent Respimat
Proair Digihaler
+ 2 more drugs
Common questions about Albuterol
Albuterol is primarily used as a 'rescue' medication to provide rapid relief from symptoms of asthma and chronic obstructive pulmonary disease (COPD). It works by relaxing the smooth muscles in the airways, which helps to open the bronchial tubes and make breathing easier during an attack. Healthcare providers also prescribe it to prevent exercise-induced bronchospasm when taken shortly before physical activity. It is effective for treating acute shortness of breath, wheezing, and chest tightness. However, it does not treat the underlying inflammation of asthma, so it is often used alongside a daily controller inhaler. Your doctor will determine the best way to incorporate Albuterol into your asthma action plan.
The most common side effects of Albuterol include tremors (shaking, especially in the hands), nervousness, and a fast or pounding heartbeat. Many patients also report feeling 'jittery' or anxious shortly after using the inhaler, which is due to the drug's stimulating effect on the nervous system. Headaches and dizziness are also frequently mentioned by patients starting the medication. These side effects are typically mild and usually wear off within an hour or two as the drug's levels in the bloodstream peak and then decline. If these symptoms become severe or cause significant distress, you should contact your healthcare provider to discuss a possible dose adjustment. Most people find that these effects become less noticeable as their body gets used to the medication.
There is no known direct chemical interaction between Albuterol and alcohol that would make the combination strictly prohibited. However, alcohol can increase your heart rate, which may add to the heart-pounding sensation or 'jitters' that Albuterol can cause. Additionally, some people find that certain types of alcohol, like red wine or beer, contain sulfites or histamines that can actually trigger an asthma attack. Drinking heavily can also impair your ability to recognize if your asthma symptoms are getting worse, which could be dangerous. It is generally best to consume alcohol only in moderation and to observe how your body reacts to the combination. Always consult your doctor if you have concerns about your lifestyle and your medications.
Albuterol is generally considered the safest rescue medication for use during pregnancy because uncontrolled asthma poses a much greater risk to the baby than the medication itself. When a mother has an asthma attack, the baby may not receive enough oxygen, which can lead to complications like low birth weight or premature delivery. Clinical data from decades of use have not shown a clear link between inhaled Albuterol and birth defects. Doctors typically recommend using the lowest effective dose to manage symptoms. It is important to keep your asthma well-controlled throughout your pregnancy under the guidance of both your obstetrician and your primary doctor. Always inform your healthcare team if your asthma symptoms change while you are pregnant.
One of the primary benefits of Albuterol is its rapid onset of action, which typically begins within 5 to 15 minutes after inhalation. Most patients will feel a significant improvement in their breathing and a reduction in wheezing shortly after the first or second puff. The medication reaches its peak effectiveness about 60 to 90 minutes after use. Because it works so quickly, it is the standard choice for treating sudden, acute symptoms. The effects of a single dose usually last between 3 and 6 hours. If you find that the medication is not working within 15 minutes, or if the relief lasts for less than 3 hours, you should seek medical attention immediately, as this indicates a severe asthma flare-up.
Yes, you can stop taking Albuterol suddenly without experiencing withdrawal symptoms, as it is a short-acting medication used primarily for symptom relief. Unlike some other medications, it does not require a tapering period to be discontinued safely. However, you should only stop using it if your breathing is stable and you no longer need it for rescue relief. It is critical to remember that Albuterol is not a cure for asthma; it only manages the symptoms. You should never stop taking your daily 'controller' or 'maintenance' medications without consulting your doctor, even if you feel fine. If you stop using Albuterol and your breathing difficulties return, you should resume use as directed by your asthma action plan.
Because Albuterol is most often used on an 'as-needed' basis for sudden symptoms, missing a dose is usually not a concern. You simply take the medication when you feel the need for it. If your doctor has prescribed Albuterol on a regular schedule and you miss a dose, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed one and return to your regular timing. Never take two doses at once or 'double up' to make up for a missed one, as this increases the risk of side effects like a racing heart or tremors. If you are frequently forgetting doses, talk to your doctor about ways to simplify your treatment plan.
No, Albuterol is not known to cause weight gain. Unlike oral corticosteroids (like prednisone), which are well-known for causing weight gain and fluid retention when used long-term, Albuterol is a bronchodilator and does not affect the body's metabolism or fat storage in the same way. In fact, because Albuterol is a stimulant, it may very slightly increase your metabolic rate, though not enough to cause weight loss. If you are experiencing weight gain while treating asthma, it is more likely related to other medications you may be taking, such as oral steroids, or a decrease in physical activity due to breathing difficulties. If you have concerns about weight changes, discuss them with your healthcare provider to identify the underlying cause.
Albuterol can be taken with many other medications, but there are some important exceptions you should discuss with your doctor. Most importantly, beta-blockers (often used for high blood pressure or heart issues) can block the effects of Albuterol and may even worsen your asthma. Certain diuretics or 'water pills' can also interact with Albuterol by lowering your potassium levels too much. It is generally safe to take Albuterol with most antibiotics, pain relievers, and daily inhaled steroids. However, you should always provide your doctor and pharmacist with a complete list of all the medicines, supplements, and vitamins you take. This ensures that they can check for any specific interactions that might affect your safety or the drug's effectiveness.
Yes, Albuterol is widely available as a generic medication, which is typically much more affordable than brand-name versions like Ventolin or ProAir. Generic Albuterol sulfate inhalation aerosol and nebulizer solutions are FDA-approved and are required to meet the same strict standards for safety, strength, and quality as the brand-name drugs. While the medication itself is the same, the design of the inhaler device (the plastic actuator) may vary slightly between different generic manufacturers. If you switch to a generic version, make sure you understand how to use the specific device provided by your pharmacy. Most insurance plans prefer generic Albuterol, making it an accessible option for the majority of patients.